$42.67-1.15 (-2.62%)
Alexandria Real Estate Equities, Inc., an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world.
Alexandria Real Estate Equities, Inc. in the Real Estate sector is trading at $42.67 with a market capitalization of $9.2B. Wall Street consensus targets $51.93 (14 analysts), implying a +21.7% move over the next 12 months. The stock is currently near its 52-week low of $39.41, remaining 12.6% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 9 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $643.21M↓ | $653.01M↓ | $728.87M↓ | $735.85M↓ | $737.28M |
| Gross Profit | $435.87M↑ | $428.87M↓ | $496.33M | $496.62M↓ | $512.85M |
| Operating Income | $94.63M↑ | $88.75M↓ | $146.25M↑ | $127.16M↓ | $137.59M |
| Net Income | -$72.78M↓ | $361.65M↑ | -$1.08B↓ | -$232.75M↓ | -$107.00M |
Alexandria Real Estate Equities, Inc., an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Ale...
Academic risk and quality models computed from ARE's own filings and price history, not from analyst opinion.
Mixed: 6 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Altman Z below 1.81, the financial-distress band. This measures balance-sheet stress, not share-price direction.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
Hidden Markov model fitted to two years of returns, separating bull, bear and sideways states by their own drift and volatility.
GARCH(1,1) 30-day annualised forecast, above the current 48.3% reading.
Fama-French 5-factor market beta. The five factors explain 17% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-10-13.